| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5699509 | Clinical Oncology | 2013 | 10 Pages |
Abstract
Skeletal-related events were generally not preceded or followed by transition to elevated NTX in patients treated with ZOL. Elevated baseline NTX and aggressive extraskeletal disease were independently associated with reduced survival.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
A. Lipton, R. Cook, J. Brown, J.J. Body, M. Smith, R. Coleman,